Literature DB >> 17459663

The significance of compliance for the success of antimicrobial prophylaxis in recurrent lower urinary tract infections: the Greek experience.

Zoi Alexiou1, Maria Mouktaroudi, George Koratzanis, Antonios Papadopoulos, Dimitra Kavatha, Kyriaki Kanellakopoulou, Helen Giamarellou, Evangelos J Giamarellos-Bourboulis.   

Abstract

In an attempt to define the most important driver responsible for recurrence of cystitis in women, 181 records were retrospectively analysed among 1010 consecutive references in a tertiary centre for lower urinary tract infections (UTIs). All 181 women had more than three episodes of cystitis per year; 129 were under continuous prophylaxis and 52 were under postcoital prophylaxis. Analysis revealed that the most important factor affecting successful outcome of chemoprophylaxis was the compliance of patients (odds ratio 0.074; P<0.0001). Among women treated for >or=6 months, the most effective regimen was nitrofurantoin, with a success rate of 96.8% compared with 82.8% for trimethoprim/sulphamethoxazole and 72.3% for norfloxacin (P=0.046 between agents). Failure of chemoprophylaxis was observed in 51 women in total; in 26 of them resistance to the administered agent had developed. Results of this retrospective study revealed that the most important driver leading to failure of prophylaxis for recurrent lower UTIs was the lack of compliance of women with their medication. Nitrofurantoin was the most potent among the administered agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459663     DOI: 10.1016/j.ijantimicag.2007.02.017

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  5 in total

1.  [Primary vesicoureteral reflux].

Authors:  R Stein; C Ziesel; P Rubenwolf; R Beetz
Journal:  Urologe A       Date:  2013-01       Impact factor: 0.639

2.  Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial.

Authors:  Elisabetta Costantini; Alessandro Zucchi; Eleonora Salvini; Annarita Cicalese; Vincenzo Li Marzi; Maria Teresa Filocamo; Vittorio Bini; Massimo Lazzeri
Journal:  Int Urogynecol J       Date:  2014-02-20       Impact factor: 2.894

Review 3.  Contemporary management of uncomplicated urinary tract infections.

Authors:  David R P Guay
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  In Vitro Activity of Oral Cephalosporins (Cefprozil and Cefixime) Against Ciprofloxacin-Resistant Enterobacteriaceae from Community-Acquired Urinary-Tract Infections.

Authors:  Aikaterini Pistiki; Thomas Tsaganos; Irene Galani; Evangelos J Giamarellos-Bourboulis
Journal:  Infect Dis Ther       Date:  2015-09-21

5.  Formulation development and stability studies of norfloxacin extended-release matrix tablets.

Authors:  Paulo Renato Oliveira; Cassiana Mendes; Lilian Klein; Maximiliano da Silva Sangoi; Larissa Sakis Bernardi; Marcos Antônio Segatto Silva
Journal:  Biomed Res Int       Date:  2013-09-08       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.